Assesement of dysfunction of oil glands of eyelid with a special instrument called lipiview

Evaluation of meibomian gland dysfunction: its correlation with lipiview and response to treatment - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086275

Enrollment

Registered

2025-05-05

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H028- Other specified disorders of eyelid

Interventions

Intervention1: treatment of meibomian gland dysfunction grade 1: warm compress and propylene glycol 0.6% lubricant eye drops thrice daily for 30 days Intervention2: treatment of meibomian gland dysfun

Eligibility

Inclusion criteria

Inclusion criteria: patients clinically diagnosed to have meibomian gland dysfunction using slit lamp biomicroscopy

Exclusion criteria

Exclusion criteria: patients with lid abnormalities patients with blepharitis patients who underwent ocular surgery in the past 3 months patients who underwent LASIK surgery patients with history of contact lens wear pregnant and lactating women patients who used chronic ocular drugs such anti histamines and anti glaucoma medications

Design outcomes

Primary

Measure	Time frame
to assess lipid layer thickness and meibomian gland morphology in different grades of meibomian gland dysfunction before and after treatmentTimepoint: o and 1 month	—

Secondary

Measure	Time frame
To correlate clinical grades of meibomian gland dysfunction with OSDI questionnaire & lipiview parametersTimepoint: at baseline & 4 weeks after treatment	—

Countries

India

Contacts

Public ContactKodipalli Sri Ramya Sai

Sankara Eye Hospital

sudhakar@sankaraeye.com8074059433

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026